Allylisopropylacetylurea
CAS: 528-92-7
Ref. 3D-FA59841
5g | Descatalogado | ||
10g | Descatalogado | ||
25g | Descatalogado | ||
50g | Descatalogado | ||
100g | Descatalogado |
Información del producto
- (2-Isopropyl-4-pentenoyl)-ureaApronalideN-(Aminocarbonyl)-2-(1-methylethyl)-4-pentenamide
- (2-Isopropyl-4-pentenoyl)urea
- 2-Allyl-2-isopropylacetylurea
- 4-Pentenamide, N-(aminocarbonyl)-2-(1-methylethyl)-
- Alipronal
- Allyl isopropyl acetylurea
- Allylisopropylacetylcarbamide
- Apronal
- Apronalide
- Brn 1775529
- Ver más sinónimos
- Isodormid
- Isopropylallylazetylkarbamid
- Isopropylallylazetylkarbamid [German]
- N-(Aminocarbonyl)-2-(1-methylethyl)-4-pentenamide
- N-carbamoyl-2-(propan-2-yl)pent-4-enamide
- Sedormid
- Urea, (2-isopropyl-4-pentenoyl)-
- [2-(Propan-2-yl)pent-4-enoyl]urea
Allylisopropylacetylurea is a drug with symptoms and uses that are not clear. It has been used to treat autoimmune diseases in human serum, but its mechanism of action is unknown. Allylisopropylacetylurea has been shown to have anti-inflammatory effects, which may be due to its ability to inhibit fatty acid synthesis and the release of inflammatory cytokines. This drug also reduces nucleotide levels in the liver cells, which can lead to an increased risk of infectious diseases. Allylisopropylacetylurea may also affect ATP levels, which can lead to fatigue or muscle weakness.